The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation after pars plana vitrectomy with long-acting gas tamponade

Ophthalmology. 2000 Mar;107(3):588-92. doi: 10.1016/s0161-6420(99)00083-4.

Abstract

Objective: To determine whether topical aqueous suppressant therapy applied after pars plana vitrectomy with gas tamponade prevents postoperative intraocular pressure (IOP) elevation.

Design: Prospective, nonrandomized comparative study.

Participants: Forty-one patients who met inclusion criteria and underwent pars plana vitrectomy with gas tamponade (SF6 18%-20% or C3F8 12%-16%) over a 1-year period.

Intervention: Treatment eyes received topical aqueous suppressants at the end of surgery.

Main outcome measures: Postoperative IOP at 4 to 6 hours, 1 day, and 1 week.

Results: Twenty-one control and 20 treatment eyes met the inclusion criteria. The IOP (in mmHg) measured at 4 to 6 hours (23.05 [control, 14.73 [treatment]) and 1 day (23.24 [control], 17.28 [treatment]) postoperatively showed a statistically significant difference between the groups (P = 0.0038) at 4 to 6 hours and a trend toward significance (P = 0.057) at 1 day. Eleven control and three treatment eyes had an IOP spike above 25 mmHg at 4 to 6 hours or 1 day postoperatively (P = 0.02), and six control eyes and one treatment eye had postoperative IOP greater than 30 mmHg. A pressure rise greater than 40 mmHg was seen in two control eyes and no treatment eyes.

Conclusions: Use of topical aqueous suppressants after pars plana vitrectomy with long-acting gas tamponade is effective in preventing significant postoperative IOP elevation in most cases.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Topical
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use*
  • Aqueous Humor / drug effects*
  • Brimonidine Tartrate
  • Clonidine / administration & dosage
  • Clonidine / analogs & derivatives
  • Clonidine / therapeutic use
  • Fluorocarbons / administration & dosage*
  • Humans
  • Intraocular Pressure / drug effects*
  • Ocular Hypertension / etiology
  • Ocular Hypertension / prevention & control*
  • Prospective Studies
  • Quinoxalines / administration & dosage
  • Quinoxalines / therapeutic use
  • Sulfonamides / administration & dosage
  • Sulfonamides / therapeutic use
  • Sulfur Hexafluoride / administration & dosage*
  • Thiophenes / administration & dosage
  • Thiophenes / therapeutic use
  • Timolol / administration & dosage
  • Timolol / therapeutic use
  • Vitrectomy / adverse effects*

Substances

  • Antihypertensive Agents
  • Fluorocarbons
  • Quinoxalines
  • Sulfonamides
  • Thiophenes
  • Brimonidine Tartrate
  • Timolol
  • apraclonidine
  • dorzolamide
  • perflutren
  • Clonidine
  • Sulfur Hexafluoride